PV

Active Director Additional Director DIN 11201756
DIN 11201756 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value •••• Premium profile

About Palak Vij

Data last updated:

Palak Vij is an Additional Director at Trichem Lifesciences Limited (since 2025). The company operates in Pharma. Trichem Lifesciences Limited reported revenue of ₹9.66 Cr (FY 2025).

DIN 11201756
Primary Designation Additional Director
Industry Pharma
First Appointment 18 Jul 2025
Oldest Company Age 22 yrs
Largest company Trichem Lifesciences Limited · ₹9.66 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trichem Lifesciences Limited U24230MH2004PLC146573
Additional Director18 Jul 20252004₹9.66 Cr (FY 2025)Active

Board colleagues of Palak Vij

Directorship timeline

Open interactive timeline →
Trichem Lifesciences Limited
Premium access

Shareholding and investment profile for Palak Vij

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Palak Vij

Palak Vij currently holds 1 directorship: Trichem Lifesciences Limited (Additional Director, since 18 Jul 2025, revenue ₹9.66 Cr (FY 2025)).

Palak Vij was first appointed on 18 Jul 2025 as Additional Director at Trichem Lifesciences Limited.

The current boards of Palak Vij's companies include Narendra Sujit Varde (Trichem Lifesciences Limited), Ramanuj Chandrashekhar Kankani (Trichem Lifesciences Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available